Woodline Partners LP Sutro Biopharma, Inc. Transaction History

Woodline Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $119,956 - $314,843	35,178 Added 90.72%	73,954 $385,000
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $301,677 - $593,660	38,776 New	38,776 $319,000
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $3.13 Million - $5.17 Million	-219,511 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $63,772 - $84,251	3,537 Added 1.64%	219,511 $4.08 Million
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $685,700 - $930,714	33,795 Added 18.55%	215,974 $4.92 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $1.85 Million - $4.37 Million	182,179 New	182,179 $3.96 Million

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.